Pharmacokinetics, metabolism, and toxicology of dichloroacetate

Drug Metabolism Reviews

Volumn 30, Issue 3, 1998, Pages 499-539

  Stacpoole, Peter W ^a,b   Henderson, George N ^a   Yan, Zimeng ^a   Cornett, Rachel ^b   James, Margaret O ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Dechlorination; Dichloroacetate; Glyoxylate; Kinetics; Lactic acidosis; Neuropathy; Oxalate; Tumorigenesis

Indexed keywords

DICHLOROACETIC ACID;

CARDIOVASCULAR DISEASE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG SAFETY; ENVIRONMENTAL EXPOSURE; EYE TOXICITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TOXICITY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PLASMA CLEARANCE; REVIEW; XENOBIOTIC METABOLISM;

EID: 0031926903     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.3109/03602539808996323     Document Type: Review

References (165)

1. R. E. Moore, Volatile compounds from marine algae, Acc. Chem. Res., 10, 40-47 (1977).
2. C. Wannstedt, D. Rotella, and J. F. Siuda, Chloroperoxidase mediated halogenation of phenols, Bull. Environ. Contam. Toxicol., 44, 282-287 (1990).
3. G. W. Gribble, Naturally occurring organo-halogen compounds - a survey, J. Nat. Prod., 55, 1353-1395 (1992).
4. P. Goldman, G. W. A. Milne, and M. T. Pignataro, Fluorine containing metabolites formed from 2-fluorobenzoic acid by Pseudomonas species, Arch. Biochem. Biophys., 118, 178-184 (1967).
5. A. M. Wuosmaa and L. P. Hager, Methylchloride transferase: a carbocation route for biosynthesis of halometabolites, Science, 249, 160-162 (1990).
6. K. Valli and M. H. Gold, Degradation of 2,4-dichlorophenol by the lignin-degrading fungus Phanerochate chrysosporium, J. Bacteriol., 173, 345-352 (1991).
7. A. J. Weightman, A. L. Weightman, and J. H. Slater, Toxic effects of chlorinated and brominated alkanoic acids on Pseudomonas putida PP3: selection at high frequencies of mutations in genes encoding dehalogenases, Appl. Environ. Microbiol., 49, 1494-1501 (1985).
8. A. Taurog, Hormone synthesis: thyroid iodine metabolism, in The Thyroid: A Fundamental and Clinical Text, 5th ed. (S. H. Inbar and L. E. Braverman, eds.), J. B. Lippincott, Philadelphia, 1986, pp. 53-97.
9. J. W. Miller and P. C. Uden, Characterization of nonvolatile aqueous chlorination products of humic substances, Environ. Sci. Technol., 17, 150-157 (1983).
10. P. C. Uden and J. W. Miller, Chlorinated acids and chloral in drinking water, J. Am. Water Works Assoc., 75, 524-527 (1983).
11. F. H. Mughal, Chlorination of drinking water and cancer: a review, J Environ. Pathol. Toxicol. Oncol., 11, 287-292 (1992).
12. R. L. Jolley, Basic issues in water chlorination: a chemical perspective, in Water Chlorination: Chemistry, Environmental Impact and Health Effects, Lewis Publ., Inc., Chelsea, MI, 1985, Vol. 5, pp. 19-38.
13. P. W. Stacpoole, The pharmacology of dichloroacetate, Metabolism, 38, 1124-1144 (1989).
14. R. R. Abbas, C. S. Seckel, J. K. Kidney, and J. W. Fisher, Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice, Drug Metab. Disp., 24, 1340-1346 (1996).
15. G. N. Henderson, Z. Yan, M. O. James, N. Davydova, and P. W. Stacpoole, Kinetics and metabolism of chloral hydrate in children: identification of dichloroacetate as a metabolite, Biochem. Biophys. Res. Commun., 235, 695-698 (1997).
16. K. Ohta and M. Takagi, Antimicrobial compounds of the marine red alga Marginisporum aberrans, Phytochemistry, 16, 1085-1086 (1977).
17. P. W. Stacpoole, Review of the pharmacologic and therapeutic effects of diisopropylammonium dichloroacetate (DIPA), J. Clin. Pharmacol., 9, 282-291 (1969).
18. P. W. Stacpoole, E. Iwamoto, and C. E. Glasgow, Diisopropylammonium dichloroacetate (DIPA): reversible antagonism towards smooth muscle stimulants and inhibition of acetylcholinesterase in the isolated guinea pig ileum, Res. Commun. Chem. Pathol. Pharmacol., 2, 439-446 (1971).
19. P. W. Stacpoole, G. W. Moore, and D. M. Kornhauser, Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia, N. Engl. J. Med., 298, 526-530 (1978).
20. G. W. Moore, L. L. Swift, D. Rabinowitz, O. B. Crofford, J. A. Oates, and P. W. Stacpoole, Reduction of serum cholesterol in two patients with homozygous familial hypercholesterolemia by dichloroacetate, Atherosclerosis, 33, 285-293 (1979).
21. P. W. Stacpoole, C. L. Barnes, M. D. Hurbanis, S. L. Cannon, and D. S. Kerr, Treatment of congenital lactic acidosis with dichloroacetate: a review, Arch. Dis. Child. (in press).
22. T. I. Wargovich, R. G. MacDonald, J. A. Hill, R. L. Feldman, P. W. Stacpoole, and C. J. Pepine, Myocardial metabolic and hemodynamic effects of dichloroacetate in patients with coronary artery disease, Am. J. Cardiol., 61, 65-70 (1989).
23. R. M. Bersin, C. Wolfe, M. Kwasman, D. Lau, C. Klinski, K. Tanaka, P. Khorrami, N. Henderson, T. DeMarco, and K. Chatterjee, Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate, J. Am. Coll. Cardiol., 23, 1617-1624 (1994).
24. P. W. Stacpoole, E. M. Harman, S. H. Curry, T. G. Baumgartner, and R. I. Misbin, Treatment of patients with lactic acidosis with dichloroacetate, N. Engl. J. Med., 309, 390-396 (1983).
25. P. W. Stacpoole, E. C. Wright, T. G. Baumgartner, R. M. Bersin, S. Buchalter, S. H. Curry, C. Duncan, R. Hackett, E. M. Harman, G. N. Hender, S. Jenkinson, J. M. Lachin, S. Schneider, J. Siegel, W. R. Summer, D. Thompson, C. Wolfe, and the DCA-Lactic Acidosis Study Group, A controlled trial of dichloroacetate treatment in patients with lactic acidosis, N. Engl. J. Med., 327, 1564-1569 (1992).
26. K. Irsigler, L. Kaspar, and H. Kritz, Dichloroacetate in biguanide-induced lacticacidosis, Lancet, 2, 1026-1027 (1977).
27. K. Irsigler, J. Brandle, I. Kaspar, H. Kritz, H. Lageder, and H. Regal, Treatment of biguanide-induced lactic acidosis with dichloroacetate, Arzneimittel-Forsch., 29, 555-559 (1979).
28. P. P. Toth, H. El-Shanti, S. Eivens, W. J. Rhead, and J. M. Klein, Transient improvement of congenital lactic acidosis in a male infant with pyruvate decarboxylase deficiency treated with dichloroacetate, J. Pediatr., 23, 427-430 (1993).
29. S. Whitehouse, R. H. Cooper, and P. J. Randle, Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids, Biochem. J., 141, 761-774 (1974).
30. P. W. Stacpoole, Lactic acidosis, Endocrinol. Metab. Clin. North Am., 22, 221-245 (1993).
31. P. W. Stacpoole, Lactic acidosis and other mitochondrial disorders, Metabolism, 46, 306-321 (1997).
32. S. H. Curry, P.-I. Chu, T. G. Baumgartner, and P. W. Stacpoole, Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate, Clin. Pharmacol. Ther., 37, 89-93 (1985).
33. S. H. Curry, A. Lorenz, P.-I. Chu, M. Limacher, and P. W. Stacpoole, Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses, Biopharm. Drug. Disp., 12, 375-390 (1991).
34. P.-I. Chu, Pharmacokinetics of sodium dichloroacetate, Ph.D. dissertation, University of Florida, 1987.
35. P. G. Wells, G. W. Moore, D. Rabin, G. R. Wilkinson, J. A. Oates, and P. W. Stacpoole, Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans, Diabetologia, 19, 109-113 (1980).
36. V. N. Jackson and A. P. Halestrap, The kinetics, substrate, and inhibitor specificity of the monocarboxylate (lactate) transporter of rat liver cells determined using the fluorescent intracellular pH indicator, 2′,7′-bis(carboxyethyl)-5(6)-carboxyfluroescein. J. Biol. Chem., 271, 861-868 (1996).
37. A. McAllister, S. P. Allison, and P. J. Randle, Effects of dichloroacetate on the metabolism of glucose, pyruvate, acetate, 3-hydroxybutyrate and palmitate in rat diaphragm and heart muscle in vitro and on extraction of glucose, lactate, pyruvate and free fatty acids by dog heart in vivo, Biochem. J., 134, 1067-1081 (1973).
38. J. L. Larson and R. J. Bull, Metabolism and lipoperoxidase activity of trichloroacetate and dichloroacetate in rats and mice, Toxicol. Appl. Pharmacol., 115, 268-277 (1992).
39. Z. Yan, M. O. James, G. N. Henderson, R. Cornett, V. K. M. M. Jayanti, N. Davydova, and P. W. Stacpoole, Pharmacokinetics and metabolism of dichloroacetate (DCA) in Sprague-Dawley rats: effect of age and diet, in Superfund Basic Research Conference, Chapel Hill, NC, February 1997.
40. G. Lukas, K. H. Vyas, S. D. Brindle, A. R. LeSher, and W. E. Wagner, Jr., Biological disposition of sodium dichloroacetate in animals and humans after intravenous administration, J. Pharm. Sci., 69, 419-421 (1980).
41. S. Krishna, W. Supanaranond, S. Pukrittayakamee, D. Karter, Y. Supputamonkol, T. M. E. Davis, P. A. Holloway, and N. J. White, Dichloroacetate for lactic acidosis in severe malaria: a pharmacokinetic and pharmacodynamic assessment. Metabolism, 43, 974-981 (1994).
42. S. Krishna, W. Supanaranond, S. Pukrittayakamee, F. Ter Kuile, M. Ruprah, and N. J. White, The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria, Br. J. Clin. Pharmacol., 41, 29-34 (1996).
43. G. N. Henderson, S. H. Curry, H. Derendorf, E. C. Wright, and P. W. Stacpoole, Pharmacokinetics of dichloroacetate in adult patients with lactic acidosis, J. Clin. Pharmacol., 37, 416-425 (1997).
44. S. H. Curry, A. Lorenz, G. N. Henderson, D. Mars, and P. W. Stacpoole, Hemodialysis studies with dichloroacetate, Eur. J. Clin. Pharmacol., 40, 613-617 (1991).
45. R. E. Shangraw and D. M. Fisher, Pharmacokinetics of dichloroacetate in patients undergoing liver transplantation, Anesthesiology, 84, 851-858 (1996).
46. S. Krishna, T. Agbenyega, B. J. Angus, G. Bedu-Addo, G. Ofori-Amanfo, G. Henderson, I. S. F. Szwandt, R. O'Brien, and P. W. Stacpoole, Pharmacokinetics and pharmacodynamics of dichloroacetate in children with lactic acidosis due to severe malaria, Q. J. Med., 88, 341-349 (1995).
47. G. N. Henderson, Z. Yan, M. O. James, and P. W. Stacpoole, Kinetics and metabolism of dichloroacetate in healthy adult volunteers, in Superfund Basic Research Conference, Chapel Hill, NC, February 1997.
48. R. E. Shangraw, R. Winter, J. Hromco, S. T. Robinson, and E. J. Gallaher, Amelioration of lactic acidosis with dichloroacetate during liver transplantation in humans, Anesthesiology, 81, 1127-1138 (1994).
49. P. W. Stacpoole, Clinical trial of dichloroacetate as adjunct therapy in the treatment of severe malaria, 46th Annual Meeting of the American Society of TMAH, Orlando, December 1997.
50. J. Caldwell, Xenobiotic acyl-coenzymes A: critical intermediates in the biochemical pharmacology and toxicology of carboxylic acids, Biochem. Soc. Trans., 12, 84-86 (1984).
51. H. S. A. Sherratt, Acyl-CoA esters of xenobiotic carboxylic acids as biochemically active intermediates, Biochem. Soc. Trans., 13, 856-858 (1985).
52. M. K. Smith, I. L. Randall, J. A. Stober, and E. J. Read, Developmental toxicity of dichloroacetonitrile: a by-product of drinking water disinfection, Fundam. Appl. Toxicol., 12, 765-772 (1989).
53. P. W. Stacpoole, H. J. Harwood, Jr., and C. E. Varnado, Regulation of rat liver hydroxymethylglutaryl coenzyme A reductase by a new class of noncompetitive inhibitors. Effects of dichloroacetate and related carboxylic acids on enzyme activity, J. Clin. Invest., 72, 1575-1585 (1983).
54. D. W. Crabb and R. A. Harris, Mechanisms responsible for the hypoglycemic actions of dichloroacetate and 2-chloroproprionate, Arch. Biochem. Biophys., 198, 145-152 (1979).
55. E. L. C. Lin, J. K. Mattox, and F. B. Daniel, Tissue distribution, excretion, and urinary metabolism of dichloroacetic-acid in the male Fischer 344 rat, J. Toxicol Environ. Health, 38, 19-32 (1993).
56. L. R. Pohl, S. D. Nelson, and G. Krishna, Investigation of the mechanism of the metabolic activation of chloramphenicol by rat liver microsomes. Identification of a new metabolite, Biochem. Pharmacol., 27, 491-496 (1978).
57. F. P. Guengerich, Cytochromes P-450, Comp. Biochem. Physiol., 89C, 1-4 (1988).
58. J. R. Halpert, F. P. Guengerich, J. R. Bend, and M. A. Correia, Selective inhibitors of cytochromes P450, Toxicol. Appl. Pharmacol., 125, 163-175 (1994).
59. K. Kaymans, G. M. Donné-Op. Den Kelder, J. M. Koppele Te, and N. P. E. Vermenlen, Cytochromes P450: their active-site structure and mechanism of oxidation, Drug Metab. Rev., 23, 325-387 (1993).
60. H.-M. Yang, W. H. Houser, and M. E. Davis, Dichloroacetic acid treatment increases hepatic CYP 2EI in male and female rats, Toxicol. Appl. Pharmacol., 141, 382-388 (1996).
61. 3 bioactivation, FASEB J., 5, A1564 (1991).
62. J. C. Lipscomb, D. A. Mahle, W. T. Brashear, and H. A. Barton, Dichloroacetic acid: metabolism in cytosol, Drug Metab. Disp., 23, 1202-1205 (1995).
63. R. Cornett, Z. Yan, G. Henderson, P. W. Stacpoole, and M. O. James, Cytosolic biotransformation of dichloroacetic acid (DCA) in the Sprague-Dawley rat, Toxicologist, 318 (1997).
64. G. Loew, J. Trudell, and H. Motulsky, Quantum chemical studies of the metabolism of a series of chlorinated ethane anesthetics, Molec. Pharmacol., 9, 152-162 (1973).
65. L. R. Greenstein, B. A. Hitt, and R. I. Mazze, Metabolism in vitro of enflurane, isoflurane, and methoxyflurane, Anesthesiology, 42, 420-424 (1975).
66. R. A. VanDyke and A. J. Gandolfi, Characteristics of a microsomal dechlorination system, Molec. Pharmacol., 11, 809-817 (1975).
67. F. P. Guengerich, D.-H. Kim, and M. Iwasaki, Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects, Chem. Res. Toxicol., 4, 168-179 (1990).
68. Z. Jayyose, D. Knobel, M. Muc, J. Erick, P. E. Thomas, and M. Kelley, Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes, J. Pharmacol. Exp. Therap., 273, 1156-1161 (1995).
69. Y.-C. Mi, T.-Y. Wong, R. V. Lloye, T. M. Heinze, S. Shelton, D. Casciano, F. F. Kadlubar, and P. P. Fu, Mouse liver microsomal metabolism of chloral hydrate, trichloroacetic acid, and trichloroethanol leading to induction of lipid peroxidation via a free radical mechanism, Drug Metab. Disp., 24, 81-90 (1996).
70. 4 in the perfused rat liver and in vivo, J. Biol. Chem., 261, 4542-4548 (1986).
71. G. G. Gibson and P. Skett, in Introduction to Drug Metabolism (G. G. Gibson and P. Skett, eds.), Chapman & Hall, New York, 1986.
72. B. Ketterer and G. J. Mulder, Glutathione conjugations, in Conjugation Reactions in Drug Metabolism (G. J. Mulder, ed.), Taylor and Francis, London, 1990, p. 307.
73. H. D. Durst, M. Milano, E. J. Kikta, Jr., S. A. Connelly, and E. Grushka, Phenacyl esters of fatty acids via crown ether catalysts for enhanced ultra-violet detection in liquid chromatography, Anal. Chem., 47, 1797-1801 (1975).
74. M. Hiraoka, Crown Compounds - Their Characteristics and Applications, Kodansha, Ltd., Tokyo/Elsevier Scientific Pub. Co., Amsterdam, 1982.
75. C. Moore and B. C. Pressman, Mechanism of action of valinomycin on mitochondria, Biochem. Biophys. Res. Commun., 15, 565-567 (1962).
76. +ions through phospholipid bilayers mediated by the antibiotics salinomycin and narasin studies by 23Na-and 39K-NMR spectroscopy, Biochim. Biophys. Acta, 1024, 193-197 (1990).
77. F. Cramer and W. Dieyschele, Occlusion compounds. XVI. Stereo-specific reactions with inclusion compounds, Chem. Ber., 92, 1739-1747 (1959).
78. D. W. Griffiths and M. L. Bender, Cycloamyloses as catalysts, Adv. Catal., 23, 209-261 (1973).
79. E. Grunwald and S. Winstein, The role of neighboring groups in replacement reactions. XV. Rate and medium effects in the alcholysis and hydrolysis of α-bromopropionate ion. The carboxylate ion group, J. Am. Chem. Soc., 70, 841-846 (1948).
80. D. Antolovic, V. J. Shiver, and E. R. Davidson, Theoretical study of α-lactone, acetoxyl diradical, and the gas-phase dissociation of the chloroacetate anion, J. Am. Chem. Soc., 110, 1375-1381 (1988).
81. E. V. Rowsell, K. Snell, J. A. Carnie, and K. V. Rowsell, The subcellular distribution of rat liver L-alanine-glyoxylate aminotransferase in relation to a pathway for glucose formation involving glyoxylate, Biochem. J., 127, 155-165 (1972).
82. 2, Arch. Biochem. Biophys., 210, 505-516 (1981).
83. P. W. Stacpoole, Diisopropylammonium dichloroacetate (DIPA) and sodium dichloroacetate (DCA): effects on intermediary metabolism in isolated rat liver parenchymal cells, Ph.D. dissertation, University of California, San Francisco, 1972.
84. J. W. Huff, Contact lens-induced edema in vitro, Invest. Ophthal. Vis. Sci., 32, 346-353 (1991).
85. F. D. Hayes, R. D. Short, and J. E. Gibson, Differential toxicity of monochloroacetate, monoflouroacetate and monoiodoacetate in rats, Toxicol. Appl. Pharmacol., 26, 93-102 (1973).
86. J. G. Mitroka, Monochloroacetic acid lethality in the rat in relation to lactic acid accumulation in the cerebrospinal fluid, Ph.D. dissertation, University of Medicine and Dentistry of New Jersey, Newark, 1989.
87. J. W. Anderson, D. Karounos, and T. Yoneyama, Dichloroacetate-induced changes in liver of normal and diabetic rats, Proc. Soc. Exp. Biol. Med., 149, 814-821 (1975).
88. S. L. Herren-Freund, M. A. Pereira, M. D. Khoury, and G. Olson, The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver, Toxicol. Appl. Pharmacol., 90, 183-189 (1987).
89. M. A. Nelson, A. J. Lansing, I. M. Sanchez, R. J. Bull and D. L. Springer, Dichloroacetic acid and trichloroacetic acid-induced DNA strand breaks are independent of peroxisome proliferation, Toxicology, 58, 239-248 (1989).
90. R. J. Bull, I. M. Sanchez, M. A. Nelson, J. L. Larson, and A. J. Lansing, Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate, Toxocology, 63, 341-359 (1990).
91. G. G. Mather, J. H. Exon, and L. D. Kohler, Subchronic 90 day toxicity of dichloroacetic and trichloroacetic acids in rats, Tocology, 64, 71-80 (1990).
92. M. A. Nelson, I. M. Sanchez, R. J. Bull, and S. R. Sylvester, Increased expression of c-myc and c-H-ras in dichloroacetate and trichloroacetate-induced liver tumors in B6C3F1 mice, Toxicology, 64, 47-57 (1990).
93. R. E. Richmond, A. B. DeAngelo, and R. Lindahl, Immunohistochemical localization of tumor-associated aldehyde dehydrogenase in formalin-fixed rat and mouse normal liver and hepatomas, Histochem. J., 22, 527-529 (1990).
94. I. M. Sanchez and R. J. Bull, Early induction of reparative hyperplasia in the liver of B6C3F1 mice treated with dichloroacetate and trichloroacetate, Toxicology, 64, 33-46 (1990).
95. J. L. Cicmanec, L. W. Condie, G. R. Olson, and S.-R. Wang, 90-day toxicity study of dichloroacetate in dogs, Fundam. Appl. Toxicol., 17, 376-389 (1991).
96. 1 mouse, Fundam. Appl. Toxicol., 16, 337-347 (1991).
97. R. E. Richmond, A. B. DeAngelo, E. L. Potter, and F. B. Daniel, The role of hyperplastic nodules in dichloroacetic acid-induced hepatocarcinogenesis in B6C3F1 male mice, Carcinogenesis, 12, 1383-1387 (1991).
98. F. B. Daniel, A. B. DeAngelo, J. A. Stober, G. R. Olsen, and N. P. Page, Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse, Fundam. Appl. Toxicol., 19, 159-168 (1992).
99. M. E. Davis, Dichloroacetic acid and trichloroacetic acid increase chloroform toxicity, J. Toxicol. Environ. Health, 37, 139-148 (1992).
100. M. K. Smith, J. L. Randall, E. J. Read, and J. A. Stober, Developmental toxicity of dichloroacetate in the rat, Teratology, 46, 217-223 (1992).
101. S. A. Bruschi and R. J. Bull, In vitro cytotoxicity of mono-, di-, and trichloroacetate and its modulation by hepatic peroxisome proliferation, Fundam. Appl. Toxicol., 21, 366-375 (1993).
102. K. Irita, Okabe, A. Koga, M. Yamakawa, J.-I. Yoshitake, and S. Takahashi, The effects of dichloroacetate on liver damage and circulating fuels in rats exposed to carbon tetrachloride, J. Gastroenterol. Hepatol., 9, 26-29 (1994).
103. L. H. Lash, Y. Xu, A. A. Elfarra, R. J. Duescher, and J. C. Parker, Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity, Drug Metab. Disp., 23, 846-853 (1995).
104. R. R. Maronpot, C. H. Anna, T. R. Devereux, G. W. Lucier, B. E Butterworth, and M. W. Anderson, Considerations concerning the murine hepatocarcinogenicity of selected chlorinated hydrocarbons, Prog. Clin. Biol. Res., 391, 305-323 (1995).
105. H. Vaino, K. Luinaenmaa, M. Kähönen, J. Nickels, E. Hietanen, J. Marniemi, and P. Peltonen, Hypolipidemia and peroxisome proliferation induced by phenoxyacetic acid herbicides in rats, Biochem. Pharmacol., 32, 2775-2779 (1983).
106. T. Yamano and S. Morita, Hepatotoxicity of trichlorfon and dichlorvis in isolated rat hepatocytes, Toxicology, 75, 69-77 (1992).
107. A. B. DeAngelo, F. B. Daniel, L. McMillan, P. Wernsing, and R. E. Savage, Jr., Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids, Toxicol. Appl. Pharmacol., 101, 285-298 (1989).
108. L. W. Chang, F. B. Daniel, and A. B. DeAngelo, Analysis of DNA strand breaks induced in rodent liver in vivo, hepatocytes in primary culture, and a human cell line by chlorinated acetic acids and chlorinated acetaldehydes, Environ. Molec. Mutagen., 20, 277-288 (1992).
109. J. Halpert and R. A. Neal, Cytochrome P-450-dependent metabolism of 1,1,2,2-tetrachloroethane to dichloroacetic acid in vitro, Biochem. Pharmacol., 30, 1366-1368 (1981).
110. U. Rannug, R. Gothe, and C. A. Wachtmeister, The mutagenicity of chloroethylene oxide, chloroacetaldehyde, 2-chloroethanol and chloroacetic acid, conceivable metabolites of vinyl chloride, Chem. Biol. Interact., 12, 251-263 (1976).
111. S. Hussain and S. Oseterman-Golkar, Comment on the mutagenic effectiveness of vinyl chloride metabolites, Chem. Biol. Interact., 12, 265-267 (1976).
112. E. K. Weisberger, Carcinogenicity studies on halogenated hydrocarbons, Environ. Health Perspect., 21, 7-16 (1977).
113. G. W. Fischer, P. Schneider, and H. Schuefler, Zur mutagenitat von dichloracetaldehyd und 2,2-dichlor-1,1,-dihydroxy-athanphosphor sauremethyl ester, möglichen metaboliten des phosphorogavischer pestizides trichlorpon, Chem. Biol. Interact., 19, 205-213 (1977).
114. G. LoFroth, The mutagenecity of dichloroacetaldehyde, Naturforschung, 33, 783-785 (1978).
115. L. Waskell, A study of the mutagenicity of anesthetics and their metabolites, Mutation Res., 57, 141-153 (1978).
116. E. R. Nestmann, I. Chu, D. J. Kowbel, and T. I. Matula, Short-lived mutagen in salmonella produced by reaction of trichloroacetic acid and dimethyl sulfoxide, Can. J. Genet. Cytol., 22, 35-40 (1980).
117. A. J. Weightman, A. L. Weightman, and J. H. Slater, Toxic effects of chlorinated and brominated alkanoic acids on pseudomonas putida PP3: selection at high frequencies of mutations in genes encoding dehalogenases, Appl. Environ. Microbiol., 49, 1494-1501 (1985).
118. V. Herbert, A. Gardner, and N. Coleman, Mutagenicity of dichloroacetate (DCA), an ingredient of the "cancer cure" pangamic acid ("vitamin B-15"), Blood, 52, 252 (1978).
119. V. Herbert, A. Gardner, and N. Coleman, Dichloroacetate - a mutagen? N. Engl. J. Med., 300, 625 (1979).
120. M. D. Gelernt and V. Hrbert, Mutagenicity of diisopropylamine dichloroacetate, the "active constituent" of vitamin B15 (pangamic acid), Nutr. Cancer, 3, 129-133 (1982).
121. D. M. DeMarini, E. Perry, and M. L. Shelton, Dichloroacetic acid and related compounds: induction of prophage in E. coli and mutagenicity and mutation spectra in Salmonella TA100, Mutagenesis, 9, 429-437 (1994).
122. M. A. Nelson and R. J. Bull, Induction of strand breaks in DNA by trichloroethylene and metabolites in rat and mouse liver in vivo, Toxicol. Appl. Pharmacol., 94, 45-54 (1988).
123. J. C. Fusco, A. J. Afshari, M. H. George, A. B. DeAngelo, R. R. Tice, T. Salman, and J. W. Allen, In vivo genotoxicity of dichloroacetic acid: evaluation with the mouse peripheral blood micronucleus assay and the single cell gel assay, Environ. Molec. Mutagen., 27, 1-9 (1996).
124. A. W. Fox, X. Yang, H. Murli, T. E. Lawlor, M. A. Cifone, and F. E. Reno, Absence of mutagenic effects of sodium dichloroacetate, Fundam. Appl. Toxicol., 32, 87-95 (1996).
125. J. M. Parrish, E. W. Austin, D. K. Stevens, D. H. Kinder, and R. J. Bull, Haloacetate-induced oxidative damage to DNA in the liver of male B6C3F1 mice, Toxicology, 110, 103-111 (1996).
126. J. V. Bruckner, W. F. MacKenzie, S. Muralidhara, R. Luthra, G. M. Kyle, and D. Accosta, Oral toxicity of carbon tetrachloride: acute, subacute, and subchronic studies in rats, Fundam. Appl. Toxicol., 6, 16-34 (1986).
127. S. G. Binane, C. F. Blackman, and D. E. House, Effect of perchloroethylene and its metabolites on intercellular communication in clone 9 rat liver cells, J. Toxicol. Environ. Health, 48, 427-437 (1996).
128. P. J. Dierickx, In vitro binding of acetic acid and its chlorinated derivatives by the soluble glutathione s-transferases from rat liver, Res. Commun. Chem. Pathol. Pharmacol., 44, 327-330 (1984).
129. R. O. Recknagel, E. A. Glende, Jr., J. A. Dolak, and R. L. Waller, Mechanisms of carbon tetrachloride toxicity, Pharmac. Ther., 43, 139-154 (1989).
130. J. L. Larson and R. J. Bull, Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate, Toxicol. Appl. Pharmacol., 115, 278-285 (1992).
131. L. H. Lash, Y. Xu, A. A. Elfarra, R. J. Deuscher, and J. C. Parker, Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity, Drug Metab. Disp., 23, 846-853 (1995).
132. K. Irani, Y. Xia, J. L. Zweier, S. J. Sollot, C. J. Der, E. R. Fearon, M. Sundaresan, T. Finkel, and P. J. Goldschmidt-Clermont, Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts, Science, 275. 1649-1652 (1997).
133. R. Katz, C. N. Tai, R. M. Diener, R. F. McConnell, and D. E. Semonick, Dichloroacetate, sodium: 3-month oral toxicity studies in rats and dogs, Toxicol. Appl. Pharmacol., 57, 273-287 (1981).
134. P. W. Stacpoole, H. G. Harwood, Jr., D. F. Cameron, S. H. Curry, D. A. Samuelson, P. E. Cornwell, and H. E. Sauberlich, Chronic toxicity of dichloroacetate: possible relation to thiamine deficiency in rats, Fundam. Appl. Toxicol., 14, 327-337 (1990).
135. A. Hodgkinson, Oxalic Acid in Biology and Medicine, Academic Press, San Diego, 1977, pp. 52-61.
136. E. A. Yount, S. Y. Felten, B. L. O'Connor, R. G. Peterson, R. S. Powell, M. N. Yum, and R. A. Harris, Comparison of the metabolic and toxic effects of 2-chloroproprionate and dichloroacetate, J. Pharmacol. Exp. Therap., 222, 501-508 (1982).
137. R. E. Linder, G. R. Klinfelter, L. F. Strader, J. D. Suarez, and C. J. Dyer, Acute spermatogenic effects of bromoacetic acids, Fundam. Appl. Toxicol., 22, 422-430 (1994).
138. G. P. Toth, K. C. Kelty, E. L. George, E. J. Read, and M. K. Smith, Adverse male reproductive effects following synchronic exposure of rats to sodium dichloroacetate, Fundam. Appl. Toxicol., 19, 57-63 (1992).
139. N. C. Cosby and W. R. Dukelow, Toxicology of maternally ingested trichloroethylene (TCE) on embryonal and fetal development in mice and of TCE metabolites on in vitro fertilization, Fundam. Appl. Toxicol., 19, 268-274 (1992).
140. M. K. Smith, J. L. Randall, E. J. Read, and J. A. Stober, Teratogenic activity of trichloroacetic acid in the rat, Teratology, 40, 445-451 (1989).
141. D. L. Epstein, G. A. Noeln, J. R. Randall, S. A. Christ, E. J. Read, J. A. Stober, and M. K. Smith, Cardiopathic effects of dichloroacetate in the fetal Long-Evans rat, Teratology, 46, 225-235 (1992).
142. J. B. Bernstine and A. E. Meyer, Passage of metabolites of chloral hydrate into amniotic fluid, Proc. Soc. Exp. Biol. Med., 84, 456-457 (1953).
143. A. L. Kerbey, P. J. Randle, R. H. Cooper, S. Whitehouse, H. T. Pask, and R. M. Denton, Regulation of pyruvate dehydrogenase in rat heart, Biochem. J., 154, 327-347 (1976).
144. G. Kurlemann, I. Paetzke, H. Mohler, H. Masur, G. Schuierer, J. Weglage, and H. G. Koch, Therapy of complex I deficiency: peripheral neuropathy during dichloroacetate therapy, Eur. J. Pediatr., 154, 928-932 (1995).
145. S. J. Goldberg, M. D. Lebowitz, E. J. Graver, and S. Hicks, An association of human congenital cardiac malformations and drinking water contaminants, J. Am. Coll. Cardiol., 16, 155-164 (1990).
146. Z. Yan, G. N. Henderson, M. O. James, and P. W. Stacpoole, Determination of dichloroacetate and its metabolites in human plasma by gas chromatography-mass spectrometry, J. Chromatogr. B, 703, 75-84 (1997).
147. E. Hietaven, M. Laitinen, M. Lang, and H. Vainio, Inducibility of mucosal drug-metabolizing enzymes of rats fed on a cholesterol-rich diet by polychlorinated biphenyl, 3-metaylcholanthrene and phenobarbitone, Pharmacology, 13, 287-296 (1975).
148. W. D. Loub, L. W. Wattenberg, and D. W. Davis, Aryl hydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants, J. Natl. Cancer. Inst., 54, 985-988 (1975).
149. A. E. Wade, B. Wu, and J. Lee, Nutritional factors affecting drug-metabolizing enzymes of the rat, Biochem. Pharmacol., 24, 785-789 (1975).
150. V. Abbott, L. Deloria, T. Guenther, E. Jeffery, A. Kotake, D. Nerland, and G. Mannering, Comparison of hepatic microsomal drug-metabolizing systems from rats fed crude and purified diets, Drug Metab. Disp., 4, 215-222 (1976).
151. H. Hoensch, C. H. Woo, S. B. Raffin, and R. Schmid, Oxidative metabolism of foreign compounds in rat small intestine: cellular localization and dependence on dietary iron, Gastroenterology, 70, 1063-1070 (1976).
152. G. J. Hopkins and C. E. West, Effects of dietary fats on pentobarbitone-induced sleeping times and hepatic microsomal cytochrome P-450 in rats, Lipids, 11, 736-740 (1976).
153. G. O. Korsrud, T. Kuiper-Goodman, E. Hasselager, H. C. Grice, and J. M. McLaughlan, Effects of dietary protein level on carbon tetrachloride-induced liver damage in rats, Toxicol. Appl. Pharmacol., 37, 1-12 (1976).
154. M. Laitinen and E. Hietanen, The copper induced modification of duodenal biotransformation reactions in rats during fat deficiency, Acta Pharmacol. Toxicol., 43, 363-367 (1978).
155. M. R. Past and D. E. Cook, Effect of diabetes on rat liver cytochrome P-450. Evidence for a unique diabetes-dependent rat liver cytochrome P-450, Biochem. Pharmacol., 31, 3329-3334 (1982).
156. G. A. Pascoe, J. Sakai-Wong, E. Soliven, and M. A. Correia, Regulation of intestinal cytochrome P-450 and heme by dietary nutrients, Biochem. Pharmacol., 32, 3027-3035 (1983).
157. A. E. Wade, R. A. White, L. C. Walton, and J. T. Bellows, Dietary fat -a requirement for induction of mixed-function oxidase activities in starved-refed rats, Biochem. Pharmacol., 34, 3747-3754 (1985).
158. M. T. Williams and L. Pendleton, Effects of inhibitors of RNA and protein synthesis on hepatic microsomal cytochrome P-450 concentration in fasted and fed rats, Biochem. Pharmacol., 34, 3661-3665 (1985).
159. P. A. Van Veld, R. D. Vetter, R. F. Lee, and J. S. Patton, Dietary fat inhibits the intestinal metabolism of the carcinogen benzo[a]pyrene in fish, J. Lipid Res., 28, 810-817 (1987).
160. Z. Amelizad, J. F. Narbonne, C. R. Wolf, L. W. Robertson, and F. Oesch, Effect of nutritional imbalances on cytochrome P-450 isozymes in rat liver, Biochem. Pharmacol., 37, 3245-3249 (1988).
161. S. K. Clinton and W. J. Visek, Wheat bran and the induction of intestinal benzo(a)pyrene hydrorylase by dietary benzo(a)pyrene, J. Nutr., 119, 395-402 (1989).
162. D. W. Rosenberg, Dietary modulation of cytochrome P450 in the small intestinal epithelium, Pharmacology, 43, 36-46 (1991).
163. T. Nakajima, Y. Koyama, and A. Sato, Dietary modification of metabolism and toxicity of chemical substances with special reference to carbohydrate, Biochem. Pharmacol., 31, 1005-1011 (1982).
164. G. K. DeKrey, L. Baecher-Steppan, J. A. Deyo, B. Smith, and N. I. Kerkvliet, Polychlorinated biphenyl-induced immune suppression: castration, but not adrenalectony or RU 38486 treatment, partially restores the suppressed cytotoxic T lymphocyte response to alloantigen, J. Pharmacol. Exp. Therap., 267, 308-315 (1993).
165. S. B. Pruett, D. K. Ensley, and P. L. Crittenden, The role of chemical-induced stress responses in immuno-suppression: a review of quantitative associations and cause-effect relationships between chemical-induced stress responses and immunosuppression, J. Toxicol. Environ. Health, 39, 163-192 (1993).